13What an ABI Can Deliver: Outcomes and Honest Expectations

FThe realistic ceiling: sound awareness plus a lip-reading boost

The original promise of the auditory brainstem implant was modest and it has largely held: give a profoundly deaf person who has no usable cochlear nerve a sense of sound again. In the largest single-centre experience, roughly nine in ten recipients perceive auditory sensations through the device and about eight in ten wear it regularly, so for most users the implant succeeds at its first job of reconnecting them to the acoustic world.

Where the ABI earns its keep day to day is as a partner to vision. Most recipients learn to detect and identify environmental sounds, and when the implant’s sound is combined with watching a talker’s face, lip-reading accuracy rises substantially, on the order of a third better than lip-reading alone and, for the best users, far more. Counselling should frame this as the expected and worthwhile outcome rather than the disappointing one.[2008][2024]

TOpen-set speech: the minority outcome, and who reaches it

Understanding speech with sound alone, without lip-reading, is the steep end of the ABI performance curve. In the classic NF2 series only a small fraction, around one in six, reach even limited open-set discrimination, and a handful score near half-correct on sentence tests. The cochlear nucleus surface that the array stimulates is a coarse and overlapping map, so the fine spectral detail speech needs is hard to deliver.

The decisive variable is why the nerve failed. When the auditory pathway distal to the brainstem is intact and the deafness comes from a cause other than a tumour, average open-set sentence scores in audition-alone testing have been reported around the high-fifties percent in adults, versus roughly ten percent in NF2 recipients, a difference that is large and statistically robust. The tumour itself, and the surgery to remove it, appear to injure the very brainstem neurons the implant must drive.[2006][2009][2008]

CWide variability and a slow, multi-year climb

Two recipients in the same group can land at opposite ends of the scale: published non-tumour adult series span from near zero to essentially perfect open-set scores. Some of this reflects array position over the nucleus, some the duration and cause of deafness, and much of it remains unexplained, so individual prediction is poor and a confident promise of a number is never appropriate.

Improvement is also slow. Unlike a typical cochlear implant, where benefit often appears within weeks, ABI users frequently continue to gain over months to years as the central auditory system adapts to an unfamiliar input and as programming is refined electrode by electrode. The clinical message is patience: early performance is a floor, not a verdict, and serial re-mapping is part of the therapy.[2009][2015]

CCounselling by group: NF2, non-tumour adult, and child

Tailor the conversation to the patient in front of you. For the NF2 adult, set expectations on sound awareness and a meaningful lip-reading aid, with open-set speech as a welcome bonus that most will not achieve; the device still preserves a place in the hearing world during sequential tumour surgery. For the non-tumour adult with an intact central pathway, open-set understanding is a genuine and common goal, while still acknowledging the spread of results.

Children implanted for cochlear nerve deficiency or a malformed inner ear are the most heterogeneous group of all. Many develop environmental-sound awareness and useful auditory support for spoken language, and some achieve open-set perception, but progress depends heavily on early implantation, additional disabilities, and intensive habilitation. Families should be counselled that the ABI is the start of a long therapeutic journey, not a one-step cure.[2024][2015][2002]